Lizi Wu

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Dna Damage Response

Cell Cycle Arrest

Epidermal Growth Factor Receptor

Induced Pluripotent Stem Cells

Top Venues

Signal transduction and targeted therapy

Nucleic acids research

This page only lists publications with an associated author ORCID identifier.

Publications

Ying Xin, Keming Li, Miao Huang, Chenyu Liang, Dietmar Siemann, Lizi Wu, Youhua Tan, Xin Tang
Biophysics in tumor growth and progression: from single mechano-sensitive molecules to mechanomedicine. Oncogene (2023)
Wei Ni, Zirong Chen, Xin Zhou, Rongqiang Yang, Mu Yu, Jianrong Lu, Frederic J Kaye, Lizi Wu
Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma. Signal transduction and targeted therapy 6 (1) (2021)
Fang Yu, Jiangbo Wei, Xiaolong Cui, Chunjie Yu, Wei Ni, Jörg Bungert, Lizi Wu, Chuan He, Zhijian Qian
Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response. Nucleic acids research 49 (10) (2021)
Xin Zhou, Jennifer W Li, Zirong Chen, Wei Ni, Xuehui Li, Rongqiang Yang, Huangxuan Shen, Jian Liu, Francesco J DeMayo, Jianrong Lu, Frederic J Kaye, Lizi Wu
Dependency of human and murine LKB1-inactivated lung cancer on aberrant CRTC-CREB activation. eLife 10 (2021)
Zirong Chen, Shuibin Lin, Jian-Liang Li, Wei Ni, Ruifeng Guo, Jianrong Lu, Frederic J Kaye, Lizi Wu
CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells. Oncogene 37 (14) (2018)